US congressman tries the legislative route to ending bias in clinical trials reporting

The weekend beckons but given the ‘transparency’ theme to the week here is something to ponder. US Congressman Tom Reed has tabled a bill in the House of Reps with the purpose of strengthening the reporting requirements on clinical trials so that negative and positive trial results are published.  It is being supported by the Cancer Mission2020 lobby group over there.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s